德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

开市前 11-05 09:21:17

2.950

+0.140

+4.98%

最高2.950	最低2.950	成交量1,000
今开2.950	昨收2.810	日振幅0.00%
总市值20.18亿	流通市值20.18亿	总股本6.84亿
成交额2,950	换手率0.00%	流通股本6.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":2.95,"timestamp":1793841612384,"preClose":2.81,"halted":0,"volume":1000,"delay":0,"changeRate":0.04982206405693954,"floatShares":684000000,"shares":684000000,"eps":-0.38,"marketStatus":"开市前","change":0.14,"latestTime":"11-05 09:21:17","open":2.95,"high":2.95,"low":2.95,"amount":2950,"amplitude":0,"askPrice":2.965,"askSize":500,"bidPrice":2.95,"bidSize":9500,"shortable":3,"etf":0,"ttmEps":0.097092,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793842200000},"marketStatusCode":1,"adr":0,"listingDate":1605801600000,"exchange":"SEHK","adjPreClose":2.81,"openAndCloseTimeList":[[1793842200000,1793851200000],[1793854800000,1793865600000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"1107542258","title":"德琪医药-B更新10月股份变动月报表，回购2,887,500股","url":"https://stock-news.laohu8.com/highlight/detail?id=1107542258","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107542258?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:13","pubTimestamp":1793783597,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年11月4日发布2026年10月股份变动月报，报告期为2026年10月1日至10月31日。根据公告显示，公司于报告期内法定注册股本维持2,000,000,000股，对应注册股本USD 200,000，上月无变化。期末已发行普通股684,055,132股，库存股5,481,500股，两项合计689,536,632股，与上月底持平。公司本月回购2,887,500股并将其列作库存股，导致已发行股份从上个月的686,942,632股减少至684,055,132股。公司确认，截至2026年10月31日，已符合香港联交所对最低公众持股量的相关规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164164876","title":"德琪医药-B回购78,000股股份，总额约21.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164164876","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164164876?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:51","pubTimestamp":1793699499,"startTime":"0","endTime":"0","summary":"2026年11月3日，德琪医药-B发布翌日披露报表显示，该公司于2026年11月3日在香港联交所场内回购股份。此次共回购78,000股普通股，占回购前已发行股本约0.0114%，每股回购价介乎每股港币2.64元至2.795元，合计耗资约港币210,288元。截至目前，公司已根据该授权累计于公开市场回购5,465,000股，占授权通过当日已发行股本的约0.8046%。公司确认此次回购符合香港联合交易所有限公司证券上市规则及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购78,000股股份，总额约21.03万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173289107","title":"德琪医药-B：11月2日回购10.80万股，耗资约30.36万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173289107","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173289107?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:13","pubTimestamp":1793614397,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年11月2日回购普通股10.80万股，占当日前已发行股本约0.0158%。本次回购的最高及最低每股价格分别为2.835港元及2.775港元，合计付出约30.36万港元。回购完成后，公司已发行股本变更为683,947,132股，库存股增至5,589,500股。据公告显示，此次股份回购依据2026年6月10日获通过的购回授权进行，该授权下公司可回购最多67,924,413股。公司表示，上述回购交易已遵守香港联合交易所有限公司相关上市规则及当地适用法规。本公告由公司董事长梅建明博士签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B：11月2日回购10.80万股，耗资约30.36万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680758267","title":"德琪医药-B(06996)11月2日斥资约30.36万港元回购10.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680758267","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680758267?lang=zh_cn&edition=full","pubTime":"2026-11-02 18:09","pubTimestamp":1793614166,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年11月2日该公司斥资约30.36万港元回购10.8万股，回购价格为每股2.775至2.835港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06996","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680717785","title":"【券商聚焦】中信证券：国内医药板块业绩持续修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680717785","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680717785?lang=zh_cn&edition=full","pubTime":"2026-11-02 08:40","pubTimestamp":1793580014,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券发布2027年医疗健康行业投资策略，“十五五”开局之年，医药行业首次列为国家新兴支柱产业，紧随其后的价格机制优化改革 、支持创新药械高定价、以及推动商业医疗保险发展等行业增量改革政策趋势，叠加国内医药行业在创新领域集中兑现等产业内外催化因素驱动下，该机构看到2026H1国内医药板块业绩持续修复，尤其是创新药、创新器械等新兴产业板块。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1994936","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","LU0588546209.SGD","02268","01530","02269","06990","06996","06160","LU0455707207.USD","01177","LU1794554557.SGD","HK0000320264.USD","09966","01951","IE00B031HY20.USD","LU1064131003.USD","02596","LU1226287529.USD","06078","02273","LU0348766576.USD","02162","159938","KCE","03759","LU2488822045.USD","01548","LU0823426480.USD","09939","LU0828237510.HKD","600030","00013","01276","02096","06821","BK0028","LU0348825331.USD","09996","KURE","01952","LU0607220059.USD","LU0708995153.HKD","LU0708995583.HKD","LU1969619763.USD","01801","01093","09926","LU0039217434.USD","LU0979878070.USD","06030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145737170","title":"德琪医药-B回购17.85万股股份，耗资约50.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145737170","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145737170?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:27","pubTimestamp":1793356069,"startTime":"0","endTime":"0","summary":"2026年10月30日，德琪医药有限公司在香港联交所公布翌日报表。公告显示，公司于当日回购178,500股普通股，占回购前已发行股份总数约0.0261%。回购价介乎每股港币2.79元至港币2.88元，合计动用资金504,708.75港元。此次回购后，公司已发行股份数量为684,055,132股，库藏股总数增至5,481,500股，整体已发行股本仍为689,536,632股。另据披露，回购后新股发行或转让库藏股的暂止期将持续至2026年11月29日。公司表示，本次回购过程已严格遵守香港联交所证券上市规则及相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购17.85万股股份，耗资约50.47万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679292976","title":"德琪医药-B(06996)10月30日斥资50.47万港元回购17.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679292976","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679292976?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:26","pubTimestamp":1793355975,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，于2026年10月30日斥资50.47万港元回购17.85万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06996","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191453673","title":"德琪医药-B回购14.2万股股份，总额约40.41万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191453673","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191453673?lang=zh_cn&edition=full","pubTime":"2026-10-29 18:12","pubTimestamp":1793268753,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月29日公告，公司在香港联交所场内回购股份14.2万股，占回购前已发行股本约0.0207%，每股回购价介乎2.8港元至2.9港元，合计耗资约40.41万港元。据公告，德琪医药-B于2026年6月10日获股东大会通过最高可回购67,924,413股的回购授权，截至目前已累计购回5,100,500股，约占授权通过当日公司已发行股份总数的0.7509%。公司确认本次回购符合香港联交所上市规则及相关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购14.2万股股份，总额约40.41万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678466252","title":"德琪医药-B：10月28日斥资30.38万港元回购10.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678466252","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678466252?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:44","pubTimestamp":1793184240,"startTime":"0","endTime":"0","summary":"南财智讯10月28日电，德琪医药-B（06996.HK）发布翌日披露报表，10月28日，公司回购10.7万股，每股最高回购价2.89港元，每股最低回购价2.79港元，平均价2.84港元，付出的总代价为30.38万港元。本次回购股份拟持作库存股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610283912266645.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610283912266645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","06996","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146109052","title":"德琪医药-B：2026年10月28日回购10.70万股股份，耗资约30.38万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146109052","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146109052?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:31","pubTimestamp":1793183514,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月28日在香港联交所发布翌日披露报表，公告显示公司当日回购普通股约10.70万股，约占其现有已发行股本的0.0156%。本次回购每股价格介乎2.785港元至2.89港元，总涉资约30.38万港元。公告同时披露，购回授权于2026年6月10日获通过，公司可据此回购最多67,924,413股。截至公告日，已于香港联交所或其他交易所合计回购4,958,500股，占购回授权通过当日公司已发行股份数目的0.73%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B：2026年10月28日回购10.70万股股份，耗资约30.38万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678924172","title":"德琪医药10月27日于港交所回购14.45万股 耗资约40.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678924172","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678924172?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:31","pubTimestamp":1793100660,"startTime":"0","endTime":"0","summary":"10月27日，德琪医药-B(06996.HK)于2026年10月27日在香港联合交易所回购14.45万股普通股，每股最高购回价HKD2.925，最低购回价HKD2.745，付出的价格总额为HKD40.42万。回购股份持作库存股份，拟注销数目为0。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-10-27/doc-iniwsmws7019453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","06996","HEXmain","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162008530","title":"德琪医药-B回购14.45万股股份，耗资约40.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162008530","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162008530?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:12","pubTimestamp":1793095923,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月27日公告称，公司在香港联交所场内回购144,500股股份，占回购前已发行股本的约0.0211%。本次回购每股最高价为2.925港元，最低价为2.745港元，合计支付404,209.85港元，折合约40.42万港元。公司回购授权于2026年6月10日获得通过，授权总数为67,924,413股，截至目前累计已回购4,851,500股，占授权决议通过当日已发行股本约0.7142%。公司确认上述股份回购符合香港联交所《主板上市规则》等相关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购14.45万股股份，耗资约40.42万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169495210","title":"德琪医药-B：10月26日回购17.30万股，耗资约50.41万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169495210","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169495210?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:31","pubTimestamp":1793017860,"startTime":"0","endTime":"0","summary":"德琪医药有限公司于2026年10月26日披露翌日披露报表，宣布当日回购普通股17.30万股，约占回购前已发行股份的0.0253%。本次回购于香港联交所场内进行，每股购回价介乎港币2.87元至2.97元，平均价格为港币2.914元，总耗资约港币50.41万元。回购完成后，公司已发行股份数目变为684,627,132股，库存股份增至4,909,500股。上述回购依据公司于2026年6月10日通过的购回授权进行，授权可回购股份总数为67,924,413股，截至目前公司已累计回购股份4,707,000股，占授权通过当日已发行股份总数约0.693%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B：10月26日回购17.30万股，耗资约50.41万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678193179","title":"德琪医药-B(06996)10月26日耗资约50.41万港元17.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678193179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678193179?lang=zh_cn&edition=full","pubTime":"2026-10-26 20:28","pubTimestamp":1793017705,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)公布，2026年10月26日耗资约50.41万港元17.3万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512710.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06996","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173158269","title":"德琪医药-B于10月23日回购14.15万股，耗资约40.38万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173158269","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173158269?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:16","pubTimestamp":1792750588,"startTime":"0","endTime":"0","summary":"2026年10月23日，德琪医药有限公司在香港联交所场内回购股份，共回购14.15万股，约占前一日公司已发行股本的0.0207%。本次回购的最高价为每股2.94港元、最低价为每股2.745港元，合计耗资40.38万港元。公司此前于2026年6月10日通过了购回授权，授权可购回股票总数为67,924,413股，迄今已累计购回4,534,000股，占授权通过当日已发行股份数目的约0.6675%。根据公告，公司在未来30日内暂不会发行新股或出售、转让任何库藏股份，直至2026年11月22日届满。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B于10月23日回购14.15万股，耗资约40.38万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677923367","title":"德琪医药-B(06996.HK)10月23日斥资40.38万港元回购14.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677923367","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677923367?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:14","pubTimestamp":1792750440,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1191","06996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146734806","title":"德琪医药-B回购24.45万股股份，总额约70.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146734806","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146734806?lang=zh_cn&edition=full","pubTime":"2026-10-22 17:56","pubTimestamp":1792662992,"startTime":"0","endTime":"0","summary":"德琪医药有限公司10月22日公告显示，公司于当日在香港联合交易所场内回购普通股合计244,500股，占回购前已发行股份总数约0.0357%。回购价格介乎每股港币2.825元至2.995元，总投入约70.40万港元。本次回购完成后，公司已发行股份由2026年10月21日的685,186,132股降至684,941,632股，库藏股相应增加至4,595,000股。公司确认已遵守香港联合交易所主板上市规则的相关规定。本次公告由公司主席梅建明博士签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购24.45万股股份，总额约70.40万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677530620","title":"德琪医药-B(06996.HK)10月21日耗资40.49万港元回购13.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677530620","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677530620?lang=zh_cn&edition=full","pubTime":"2026-10-21 18:06","pubTimestamp":1792577179,"startTime":"0","endTime":"0","summary":"格隆汇10月21日丨德琪医药-B(06996.HK)发布公告，2026年10月21日耗资40.49万港元回购13.3万股，回购价格每股2.995-3.1港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261021/32404076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","BK1191","06996","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172117513","title":"德琪医药-B回购13.3万股股份，耗资约40.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172117513","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172117513?lang=zh_cn&edition=full","pubTime":"2026-10-21 17:45","pubTimestamp":1792575957,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月21日公告称，当日通过香港联交所场内在二级市场回购13.3万股股份，占回购前公司已发行股本约0.0194%。本次回购价格介乎每股2.995港元至3.1港元，总金额约40.49万港元。公告显示，本次回购完成后，公司已发行股份数降至685,186,132股，库藏股数量增至4,350,500股，公司总股份数仍为689,536,632股。公司强调，本次回购行为已遵守《香港联合交易所有限公司证券上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B回购13.3万股股份，耗资约40.49万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165401161","title":"德琪医药-B(06996)：10月20日回购13.45万股，总额约40.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165401161","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165401161?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:45","pubTimestamp":1792489544,"startTime":"0","endTime":"0","summary":"德琪医药-B于2026年10月20日公告，披露当日通过香港联交所场内回购13.45万股普通股，占当日现有已发行股本约0.0196%，最高回购价每股3.065港元，最低回购价每股2.96港元，涉及总金额约40.49万港元。回购后，公司已发行股本由685,453,632股降至685,319,132股，库藏股数由4,083,000股增至4,217,500股。公司称，本次回购事宜依据2026年6月10日通过的购回授权进行，授权尚余67,924,413股可回购。公司同时表示，已遵守香港联合交易所有限公司主板上市规则等相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德琪医药-B(06996)：10月20日回购13.45万股，总额约40.49万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.0106},{"period":"1month","weight":-0.1711},{"period":"3month","weight":-0.2868},{"period":"6month","weight":-0.4242},{"period":"1year","weight":-0.4289},{"period":"ytd","weight":-0.2586}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.005},{"period":"3month","weight":-0.0631},{"period":"6month","weight":-0.0937},{"period":"1year","weight":-0.0783},{"period":"ytd","weight":-0.0668}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.088806},{"month":2,"riseRate":0.166667,"avgChangeRate":0.291534},{"month":3,"riseRate":0.5,"avgChangeRate":0.091928},{"month":4,"riseRate":0.5,"avgChangeRate":-0.034689},{"month":5,"riseRate":0.5,"avgChangeRate":0.014763},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.127204},{"month":7,"riseRate":0.333333,"avgChangeRate":0.018605},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.036567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.026777},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004922},{"month":11,"riseRate":0.666667,"avgChangeRate":0.047886},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.002542}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}